Zhitao Liang

Zhitao Liang

Auto-generated profile, based on publicly available information

Zhitao Liang

School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong Special Administrative Region, China

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2010 in Planta Medica
Verified
Journal Article
Closed access
PDF file
ZZZhong-Zhen Zhao
Zhong-Zhen Zhao
ZLZhitao Liang
Zhitao Liang
KCKelvin Chan
Kelvin Chan
GLGuanghua Lu
Guanghua Lu
ELEko Lai Mei Lee
Eko Lai Mei Lee
LLLin Li
Lin Li
Processing of Chinese Materia Medica (CMM) is a pharmaceutical technique to fulfill the different requirements of therapy, dispensing and making preparations according to traditional Chinese medicine theory. The aims of processing are to enhance the efficacy and/or reduce the toxicity of crude drugs. Those processed products are named as decoction pieces, which are used in clinics. Therefore, there is a close relationship between processing, safety, and efficacy of Chinese medicines. Some toxicity or side effects are caused by improper processing methods and some are due to improper combination of herbal mixtures. Standardization of processing methods for Chinese herbs is as important as authentication to maintain their quality and ensure their safe use. The objective of this paper is to review the literature covering the current situation and problems of CMM processing as well as recent progress in research in this area. A summary of the most urgent work needed is proposed.

1 June 2015 in LWT
Verified
Journal Article
Closed access
TYTao YI
Tao YI
LZLin Zhu
Lin Zhu
WPWan-Ling Peng
Wan-Ling Peng
XHXi-Cheng He
Xi-Cheng He
HCHong-Li Chen
Hong-Li Chen
HCHubiao Chen
Hubiao Chen

1 April 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ZZZhong-Zhen Zhao
Zhong-Zhen Zhao
ZLZhitao Liang
Zhitao Liang
GPGuo Ping
Guo Ping

12 June 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
LZLin Zhu
Lin Zhu
ZLZhi-Tao Liang
Zhi-Tao Liang
TYTao YI
Tao YI
YMYue Ma
Yue Ma
ZZZhong-Zhen Zhao
Zhong-Zhen Zhao
HCHubiao Chen
Hubiao Chen
Bupleuri Radix (Chaihu) represents one of the most successful and widely used herbal medicines in Asia for the treatment of many diseases such as inflammatory disorders and infectious diseases over the past 2000 years. In the Chinese Pharmacopoeia, Chaihu is recorded as the dried roots of Bupleurum chinense DC. and B. scorzonerifolium Willd. (Umbelliferae). However, the widespread demand for the herb has tended to far outstrip the supply. Whether the aerial parts, which account for 70 ~ 85% of the dry weights of Bupleurum species, could be used as an alternative for the root has become an important scientific issue for the sustainable utilization of Bupleurum species. On the other hand, in some areas including the southeast of China as well as in Spain, the aerial parts of Bupleurum species have already been used in the folk medications. Therefore, to clarify whether the root and aerial parts of Bupleurum species are “equivalent” in the types and quantities of chemical constituents which subsequently influence their biological activities and therapeutic effects is of great importance for both the rational and sustainable use of this herb. In the present study, the chemical profiles between the root and aerial parts of Bupleurum species from different species and collected from various locations were analyzed and compared by the ultra-high performance liquid chromatography quadrupole/time of flight-mass spectrometry (UHPLC-QTOF-MS). A total of 56 peaks were identified in the root and/or aerial parts from different batches of Bupleurum species, by comparison of references standards or with those reported in the literature. Principal Component Analysis (PCA) was conducted for displaying the differentiating clustering between these two parts. The results disclosed the distinct variations between them, which indicated that the aerial parts could not be used as an alternative of root from a chemodiversity perspective. The differentiating markers resulted from the PCA analysis could also be utilized for the differentiation between them. Further validation of their biological differences is anticipated in the future study.

12 August 2010 in Chinese Medicine
Verified
Journal Article
Open access
PDF file
ZLZhitao Liang
Zhitao Liang
HCHubiao Chen
Hubiao Chen
ZYZhiling Yu
Zhiling Yu
ZZZhong-Zhen Zhao
Zhong-Zhen Zhao
Background: Radix Polygoni Multiflori is the dried root tuber of Polygonum multiflorum Thunb. (Fam. Polygonaceae). According to Chinese medicine theory, raw (R-RPM) and processed (P-RPM) Radix Polygoni Multiflori possess different properties. The present study investigates the differences in chemistry between raw and processed Radix Polygoni Multiflori. Methods: Five pairs of R-RPM and P-RPM as well as 15 commercial decoction pieces were analyzed with high performance liquid chromatography (HPLC) and mass spectrometry (MS). Results: Two anthraquinones, namely emodin-8-O-(6'-O-malonyl)-glucoside and physcion-8-O-(6'-O-malonyl)-glucoside disappeared or decreased significantly and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucopyranoside, emodin-8-O-β-D-glucopyranoside and physcion-8-O-β-D-glucopyranoside decreased after the R-RPM samples being processed. On the other hand, the contents of emodin and physcion generally increased after processing. Conclusion: The present study indicates that processing Radix Polygoni Multiflori may change the contents and types of chemicals in it. These changes are probably responsible for the various pharmacological effects of R-RPM and P-RPM as well as hepatotoxicity.

1 May 2014 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
TYTao YI
Tao YI
LZLin Zhu
Lin Zhu
YTYi-Na Tang
Yi-Na Tang
JZJian-Ye Zhang
Jian-Ye Zhang
ZLZhi-Tao Liang
Zhi-Tao Liang
HCHubiao Chen
Hubiao Chen